Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9015990 | 0.92 | HTT (0.44) | HTTPOLBCYP1A2CYP2D6ADRA2A | |
| SCHEMBL9053303 | 0.83 | HTT (0.44) | HTTPOLBCYP1A2CYP2D6ADRA2A | |
| SCHEMBL688109 | 0.82 | THRA (0.46) | HTTPOLBADRA2AOPRK1MAPT | |
| SCHEMBL2910532 | 0.79 | POLB (0.62) | HTTPOLBSMN1; SMN2BLMKDM4E | |
| SCHEMBL8600805 | 0.77 | HTT (0.44) | HTTPOLBCYP1A2CYP2D6ADRA2A | |
| SCHEMBL4492895 | 0.77 | HTT (0.44) | HTTPOLBKDM4EHSD17B10TP53 | |
| SCHEMBL13954030 | 0.76 | POLB (0.54) | HTTPOLBSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL7705104 | 0.75 | ALDH1A1 (0.45) | HTTPOLBCYP1A2PKMHIF1A | |
| SCHEMBL7095589 | 0.74 | MEN1 (0.52) | POLBKDM4ETP53GAAMAPT | |
| SCHEMBL14407309 | 0.74 | HTT (0.59) | HTTPOLBSMN1; SMN2BLMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0901469-B1 | ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS | UNIV MONASH (AU) | 2003-08-27 | — | — | EP | disclosed |
| US-6232314-B1 | SUCH AS 1-(2-(4-CHLOROPHENYL)-2-HYDROXY)ETHYL-4-(3,5-BIS(1,1-DIMETHYLETHYL)-4 -HYDROXYPHENYL)METHYLPIPERAZINE; USED TO TREAT STROKE, CARDIAC ARREST, ISCHAEMIA, HYPOXIA, HYPOGLYCAEMIA, EPILEPSY, AND AMYOTROPHIC LATERAL SCLEROSIS | MONASH UNIVERSITY (AU) | 2001-05-15 | — | — | US | disclosed |
| EP-0901469-A4 | ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS | UNIV MONASH (AU) | 2000-11-15 | — | — | EP | disclosed |
| EP-0901469-A1 | ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS | MONASH UNIVERSITY (AU) | 1999-03-17 | — | — | EP | disclosed |
| WO-1997043259-A1 | ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS | MONASH UNIVERSITY (AU) | 1997-11-20 | — | — | WO | disclosed |